22 May 2013
Keywords: gsk, starts, testing, new, anti-counterfeiting, technology, usa
Article | 03 April 2006
In the USA, GlaxoSmithKline has begun distributing a medicine tagged with radio-frequency identification (RFID) technology as part of a pilot
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 April 2006
21 May 2013
© 2013 thepharmaletter.com